Related references
Note: Only part of the references are listed.Role of Immunotherapy in Triple-Negative Breast Cancer
Tanya E. Keenan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Tumor-Associated Macrophage Status in Cancer Treatment
Anna Maria Malfitano et al.
CANCERS (2020)
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation
Zhi-Ling Li et al.
NATURE COMMUNICATIONS (2020)
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1
Cecilia Roux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Select sequencing of clonally expanded CD8+ T cells reveals limits to clonal expansion
Huang Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung
Caroline Laheurte et al.
BRITISH JOURNAL OF CANCER (2019)
Titin mutation associated with responsiveness to checkpoint blockades in solid tumors
Qingzhu Jia et al.
JCI INSIGHT (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
PPP2R2B hypermethylation causes acquired apoptosis deficiency in systemic autoimmune diseases
Iris K. Madera-Salcedo et al.
JCI INSIGHT (2019)
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
Masao Hashimoto et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega et al.
CANCER CELL (2018)
Macrophage targeting: opening new possibilities for cancer immunotherapy
Luca Cassetta et al.
IMMUNOLOGY (2018)
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment
Elisa Peranzoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Metabolic Control of CD8+ T Cell Fate Decisions and Antitumor Immunity
Lianjun Zhang et al.
TRENDS IN MOLECULAR MEDICINE (2018)
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Leeat Keren et al.
CELL (2018)
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y. Janjigian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response
Benjamin A. Kansy et al.
ONCOIMMUNOLOGY (2018)
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
Eric Shifrut et al.
CELL (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Immunotherapy and Prevention of Pancreatic Cancer
Alexander H. Morrison et al.
TRENDS IN CANCER (2018)
Breast Cancer Immunotherapy: Facts and Hopes
Leisha A. Emens
CLINICAL CANCER RESEARCH (2018)
PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer
Henan Zhao et al.
MOLECULES (2017)
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
Teresa Davoli et al.
SCIENCE (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence
Alexandre Reuben et al.
CANCER DISCOVERY (2017)
Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity
Xiuli Zhang et al.
CANCER IMMUNOLOGY RESEARCH (2017)
ChAMP: updated methylation analysis pipeline for Illumina BeadChips
Yuan Tian et al.
BIOINFORMATICS (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects
Hongyan Jia et al.
DRUG RESISTANCE UPDATES (2017)
Targeting neoantigens to augment antitumour immunity
Mark Yarchoan et al.
NATURE REVIEWS CANCER (2017)
Cancer Neoantigens and Applications for Immunotherapy
Alexis Desrichard et al.
CLINICAL CANCER RESEARCH (2016)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Sticking It to Cancer with Molecular Glue for SHP2
Hao Ran et al.
CANCER CELL (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy
Rajarsi Mandal et al.
CANCER DISCOVERY (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
JOURNAL OF CLINICAL INVESTIGATION (2015)
Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus-Targeted Tumor-Infiltrating T Cells
Sanja Stevanovic et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Scott D. Brown et al.
GENOME RESEARCH (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer Patients
Anita Sveen et al.
CLINICAL CANCER RESEARCH (2012)
Assessment of palindromes as platforms for DNA amplification in breast cancer
Jamie Guenthoer et al.
GENOME RESEARCH (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Dephosphorylation of Carma1 by PP2A negatively regulates T-cell activation
Andrea C. Eitelhuber et al.
EMBO JOURNAL (2011)
Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS
Yongguang Tao et al.
NUCLEIC ACIDS RESEARCH (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
B55β-Associated PP2A Complex Controls PDK1-Directed Myc Signaling and Modulates Rapamycin Sensitivity in Colorectal Cancer
Jing Tan et al.
CANCER CELL (2010)
Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
Aslaug Aa Muggerud et al.
BREAST CANCER RESEARCH (2010)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q
B. Orsetti et al.
BRITISH JOURNAL OF CANCER (2006)
Share Paper
